QuidelOrtho (QDEL) Cash from Financing Activities (2021 - 2026)
QuidelOrtho recorded quarterly Cash from Financing Activities of $37.6 million in Q1 2026, up 438.74% quarter-over-quarter from -$11.1 million in Q4 2025, and up 113.64% year-over-year from $17.6 million in Q1 2025.
QuidelOrtho's Cash from Financing Activities history runs 6 years deep, the most recent figure standing at $37.6 million for Q1 2026.
- In Q1 2026, Cash from Financing Activities rose 113.64% year-over-year to $37.6 million; the TTM figure through Mar 2026 stood at $175.8 million (up 107.07% YoY), while the FY2025 annual figure was $155.8 million, up 219.26% from the prior year.
- Cash from Financing Activities came in at $37.6 million for Q1 2026 at QuidelOrtho, up from -$11.1 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $424.2 million in Q1 2023 to a low of -$99.7 million in Q3 2023.
- A 5-year average of $26.5 million and a median of -$11.1 million in 2025 frame the typical range for Cash from Financing Activities.
- Across the five-year window, Cash from Financing Activities sank 1652.94% in 2023 and surged 274.9% in 2025, its largest moves.
- QuidelOrtho's Cash from Financing Activities stood at -$3.4 million in 2022, then plunged by 1600.0% to -$57.8 million in 2023, then decreased by 19.2% to -$68.9 million in 2024, then soared by 83.89% to -$11.1 million in 2025, then jumped by 438.74% to $37.6 million in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered $37.6 million, -$11.1 million, and $46.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -97.90 Mn |
| 10 | QuidelOrtho | 898.19 Mn | 757.79 Mn | - | 37.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 37.60 Mn |
| Mar 29, 2026 | 37.60 Mn |
| Dec 28, 2025 | -11.10 Mn |
| Dec 28, 2025 | -11.10 Mn |
| Sep 28, 2025 | 46.00 Mn |
| Sep 28, 2025 | 46.00 Mn |
| Jun 29, 2025 | 103.30 Mn |
| Jun 29, 2025 | 103.30 Mn |
| Mar 30, 2025 | 17.60 Mn |
| Mar 30, 2025 | 17.60 Mn |
| Dec 29, 2024 | -68.90 Mn |
| Dec 29, 2024 | -68.90 Mn |
| Sep 29, 2024 | -26.30 Mn |
| Sep 29, 2024 | -26.30 Mn |
| Jun 30, 2024 | 162.50 Mn |
| Jun 30, 2024 | 162.50 Mn |
| Mar 31, 2024 | -18.50 Mn |
| Mar 31, 2024 | -18.50 Mn |
| Dec 31, 2023 | -57.80 Mn |
| Dec 31, 2023 | -57.80 Mn |
| Oct 1, 2023 | -48.70 Mn |
| Oct 1, 2023 | -48.70 Mn |
| Jul 2, 2023 | -99.70 Mn |
| Jul 2, 2023 | -99.70 Mn |
| Apr 2, 2023 | -59.60 Mn |
| Apr 2, 2023 | -59.60 Mn |
| Jan 1, 2023 | 424.20 Mn |
| Jan 1, 2023 | 424.20 Mn |
| Apr 3, 2022 | -3.40 Mn |
| Apr 3, 2022 | -3.40 Mn |
| Oct 3, 2021 | 1.80 Mn |
| Oct 3, 2021 | 1.80 Mn |